- Home
- RCUS vs ESTA Comparison
RCUS vs ESTA Comparison
Compare RCUS & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | ESTA |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.0B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RCUS | ESTA |
|---|---|---|
| Price | $24.89 | $66.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | $31.90 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 1.5M | 278.4K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | $61,208,000.00 |
| Revenue This Year | N/A | $28.05 |
| Revenue Next Year | $45.62 | $26.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 76.49 |
| 52 Week Low | $12.87 | $38.35 |
| 52 Week High | $31.74 | $97.59 |
Technical Indicators
Market Signals| Indicator | RCUS | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 35.57 |
| Support Level | $22.92 | $64.11 |
| Resistance Level | $26.43 | $68.27 |
| Average True Range (ATR) | 1.30 | 2.56 |
| MACD | -0.10 | -0.15 |
| Stochastic Oscillator | 24.23 | 12.78 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.